Serum Institute of India seeks regular marketing authorisation from DCGI for Covishield

Pointing out that over 100 crore doses of Covishield have been supplied in India and many other countries, Serum Institute of India on Monday sought regular marketing approval for the Covid-19 vaccine, which is currently authorised for emergency use in the country, official sources said. The application sent to the Drugs Controller General of India (DCGI) by Prakash Kumar

Related Keywords

Chile ,Peru ,India ,United Kingdom ,Brazil ,Pune ,Maharashtra ,Prakash Kumar Singh ,Biontech Covid ,Narendra Modi ,Adarc Poonawalla ,Aatmanirbhar Bharat ,Mansukh Mandaviya ,Team Government Of India ,Union Health ,Central Drugs Standard Control Organisation ,Regulatory Affairs At Serum Institute Of India ,Pfizer ,Serum Institute Of India On ,Expert Committee ,Team Serum Institute Of India ,Serum Institute ,Drugs Controller General ,Regulatory Affairs ,Prime Minister Narendra Modi ,Bharat Biotech ,South Africa ,Subject Expert Committee ,Union Health Minister Mansukh Mandaviya ,Team Government ,Team Serum Institute ,Coronavirus Vaccine ,Covishield ,Cgi ,Ndia News ,Serum Institute Of India ,